alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
LOSS PROVISION FOR DOUBTFUL ACCOUNTS IS INCLUDED IN TOTAL COSTS.  INTEREST
EXPENSE IS PRESENTED NET OF INTEREST INCOME OF $34 AND $80, RESPECTIVELY.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1995             DEC-31-1995
<PERIOD-START>                             SEP-30-1995             JAN-01-1995
<PERIOD-END>                               DEC-31-1995             DEC-31-1995
<CASH>                                             812                     812
<SECURITIES>                                       258                     258
<RECEIVABLES>                                    8,220                   8,220
<ALLOWANCES>                                       372                     372
<INVENTORY>                                     10,557                  10,557
<CURRENT-ASSETS>                                20,317                  20,317
<PP&E>                                          17,063                  17,063
<DEPRECIATION>                                   8,116                   8,116
<TOTAL-ASSETS>                                  29,500                  29,500
<CURRENT-LIABILITIES>                            3,175                   3,175
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                         6,396                   6,396
<OTHER-SE>                                      19,729                  19,729
<TOTAL-LIABILITY-AND-EQUITY>                    29,500                  29,500
<SALES>                                         10,332                  46,300
<TOTAL-REVENUES>                                10,332                  46,300
<CGS>                                            7,366                  31,957
<TOTAL-COSTS>                                    9,703                  42,308
<OTHER-EXPENSES>                                  (41)                    (82)
<LOSS-PROVISION>                                  (58)                      66
<INTEREST-EXPENSE>                                (20)                    (30)
<INCOME-PRETAX>                                    690                   4,104
<INCOME-TAX>                                        23                   1,280
<INCOME-CONTINUING>                                667                   2,824
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                       667                   2,824
<EPS-PRIMARY>                                      .19                     .79
<EPS-DILUTED>                                      .19                     .79
        

</TABLE>
[985 NE2d 423, 961 NYS2d 828]

#### In the Matter of Willard Saperston, Appellant, v Heather Holdaway, Respondent.

Decided February 19, 2013

APPEARANCES OF COUNSEL

*Phillips Lytle LLP,*Buffalo *(Michael B. Powers*of counsel), for appellant.

*Peter C. Lomtevas, Esq., P.C.,*Brooklyn *(Peter C. Lomtevas*of counsel), for respondent.

*Bouvier Partnership, LLP,*Buffalo *(Emilio L. Colaiacovo*of counsel), Attorney for the Child.

OPINION OF THE COURT

On review of submissions pursuant to section 500.11 of the Rules of the Court of Appeals (22 NYCRR 500.11), appeal *1053dismissed, without costs, upon the ground that the two-Justice dissent at the Appellate Division is not on a question of law within the meaning of CPLR 5601 (a).

Concur: Chief Judge Lippman and Judges Graffeo, Read, Smith and Pigott. Judge Rivera taking no part.
#### In the Matter of Louis Rosado, for Reinstatement to the Practice of Law in the State of New York.

[977 NYS2d 664]

Order entered terminating suspension and reinstating petitioner to the practice of law. Present — Smith, J.P., Fahey, Garni, Sconiers and Valentino, JJ. (Filed Dec. 13, 2013.)
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
unaudited consolidated financial statements of Sybron International Corporation
for the three months ended December 31, 1999 and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-START>                             OCT-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                          22,003
<SECURITIES>                                         0
<RECEIVABLES>                                  230,480
<ALLOWANCES>                                     5,202
<INVENTORY>                                    218,809
<CURRENT-ASSETS>                               514,366
<PP&E>                                         248,872
<DEPRECIATION>                                 225,583
<TOTAL-ASSETS>                               1,935,238
<CURRENT-LIABILITIES>                          176,183
<BONDS>                                        963,471
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,040
<OTHER-SE>                                     646,180
<TOTAL-LIABILITY-AND-EQUITY>                 1,935,238
<SALES>                                        298,247
<TOTAL-REVENUES>                               298,247
<CGS>                                          144,057
<TOTAL-COSTS>                                   85,505
<OTHER-EXPENSES>                                   222
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              17,923
<INCOME-PRETAX>                                 50,540
<INCOME-TAX>                                    20,116
<INCOME-CONTINUING>                             30,424
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    30,424
<EPS-BASIC>                                        .29
<EPS-DILUTED>                                      .29


</TABLE>
EX-10.1



 Exhibit 10.1 
 Non-Employee Director Compensation 
 Adopted by the Board of Directors:
May 23, 2013 
  

					
	 Element of Compensation
	  	Amount	 
	 Base (annual amount in cash, paid in quarterly installments)
	  	$	50,000	  
	 Chairperson adders (annual amounts in cash, paid in quarterly installments)
	  			
	 Chairman of the Board
	  	$	60,000	  
	 Compensation Committee Chair
	  	$	12,500	  
	 Audit Committee Chair
	  	$	10,000	  
	 Nomination and Governance Committee Chair
	  	$	6,000	  
	 Annual Equity Grant 1
	  	$	75,000	  

  

	1.	The equity component is paid annually on the date of the Corporation’s Annual Meeting of Shareholders in fully-vested shares of the Corporation’s common stock
valued based on the closing price on such date, rounded up or down to eliminate the issuance of fractional shares.
[Federal Register Volume 74, Number 118 (Monday, June 22, 2009)]
[Notices]
[Page 29495]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-14497]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health & Human 
Development; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel. Attention Trajectories from 5 to 
7 Years.
    Date: June 25, 2009.
    Time: 2 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6100 Executive Boulevard 
Room 5B01, Rockville, MD 20852. (Telephone Conference Call).
    Contact Person: Carla T. Walls, PhD, Scientific Review 
Administrator, Division of Scientific Review, National Institute of 
Child Health and Human Development, NIH, 6100 Executive Blvd., Room 
5B01, Bethesda, MD 20892. (301) 435-6898. <a href="/cdn-cgi/l/email-protection#5324323f3f2030133e323a3f7d3d3a3b7d343c25"><span class="__cf_email__" data-cfemail="b2c5d3dedec1d1f2dfd3dbde9cdcdbda9cd5ddc4">[email protected]</span></a>.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: June 12, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-14497 Filed 6-19-09; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Prepared by MERRILL CORPORATION









Exhibit

10.36




 




 




AMENDMENT TO PROMISSORY NOTE




 




This AMENDMENT TO PROMISSORY NOTE (the

“Amendment”) is made this 31st day of August 2001, between EpicEdge, Inc., a

Texas corporation (“Maker”), and Carl R. Rose 

(“Payee”).




 




PREAMBLE




 




WHEREAS, Maker executed a Convertible Promissory

Note on the 7th day of November, 2000 whereby it promised to pay to

the order of Payee the sum of $400,000, (the “Original Note”), and




 




WHEREAS, in order to maximize the purposes for which

the Original Note was procured, Maker and Payee have agreed to amend the

payment terms.




 




NOW, THEREFORE, in exchange for ten and

no/100 dollars ($10), the mutual promises contained herein, and other good and

valuable consideration, the receipt and sufficiency of which are hereby

acknowledged, the parties hereto agree to amend the Original Note as follows:




 




1.     Section (a) of the

introductory paragraph of the Original Note shall be amended to reflect that

interest shall be paid based on the principal amount plus accrued interest

commencing September 1, 2001;




 




2.     Section 1(b) of the

Original Note shall be deleted;




 




3.     Section 3(a) of the

Original Note shall be amended to increase the conversion rate from fifty cents

($.50) to one dollar ($1.00);




 




4.     Section 2 of the Original

Note shall be amended to increase the cure period upon written notice of an

event of default from ten (10) days to thirty (20) days;




 




5.     Section (b) of introductory

paragraph of the Original Note shall be amended to reflect that the principal

shall mature on December 1, 2002. If the company defaults, the Payee has at its

sole discretion the right to either convert the note at $.50 per share, demand

payment or to extend the maturity date until December 1, 2003. If the company

again defaults, the Payee has at its sole discretion the right to either

convert the note at $.25 per share, demand payment or extend the maturity date

until December 1, 2004.




 




6.     All other terms of the

Original Note shall remain unmodified.













 




IN WITNESS WHEREOF, each of the parties hereto

has executed this Amendment or has caused this Amendment to be executed on its

behalf by a representative duly authorized, all as of the date first above set

forth.




 




	

  MAKER:


  	

   


  
	

   


  	

   


  	

   


  
	

  EPICEDGE,

  INC.


  	

   


  
	

   


  	

   


  	

   


  
	

  By:


  	

   


  	

   


  
	

  Name:


  	

   


  	

   


  
	

  Title:


  	

   


  	

   


  
	

   


  	

   


  	

   


  
	

  PAYEE:


  	

   


  
	

   


  	

   


  	

   


  
	

   


  	

   


  
	

  CARL R.

  ROSE
[Federal Register Volume 74, Number 117 (Friday, June 19, 2009)]
[Notices]
[Pages 29196-29197]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-14427]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy

[Docket ID: USN-2008-0059]


Submission for OMB Review; Comment Request

ACTION: Notice.

-----------------------------------------------------------------------

    The Department of Defense has submitted to OMB for clearance, the 
following proposal for collection of information under the provisions 
of the Paperwork Reduction Act (44 U.S.C. Chapter 35).

DATES: Consideration will be given to all comments received by July 20, 
2009.
    Title, Form, and OMB Number: Enlistee Financial Statement: NAVCRUIT 
Form 1130/13; OMB Control Number 0703-0020.
    Type of Request: Extension.
    Number of Respondents: 3,300.
    Responses per Respondent: 1.
    Annual Responses: 3,300.
    Average Burden per Response: 45 minutes.
    Annual Burden Hours: 2,475.
    Needs and Uses: All persons interested in entering the U.S. Navy or 
U.S. Navy Reserve, who have someone either fully or partially dependent 
on them for financial support, must provide information on their 
current financial situation which will determine if the individual will 
be able to meet their financial obligations on Navy pay. The 
information is provided on NAVCRUIT Form 1130/13 by the prospective 
enlistee during an interview with a Navy recruiter.
    Affected Public: Individuals or households.
    Frequency: On occasion.
    Respondent's Obligation: Required to obtain or retain benefits.
    OMB Desk Officer: Ms. Jasmeet Seehra.
    Written comments and recommendations on the proposed information 
collection should be sent to Ms. Seehra at the Office of Management and 
Budget, Desk Officer for DoD, Room 10236, New Executive Office 
Building, Washington, DC 20503.
    You may also submit comments, identified by docket number and 
title, by the following method:
    <bullet> Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments.

[[Page 29197]]

    Instructions: All submissions received must include the agency 
name, docket number and title for this Federal Register document. The 
general policy for comments and other submissions from members of the 
public is to make these submissions available for public viewing on the 
Internet at http://www.regulations.gov as they are received without 
change, including any personal identifiers or contact information.
    DoD Clearance Officer: Ms. Patricia Toppings.
    Written requests for copies of the information collection proposal 
should be sent to Ms. Toppings at WHS/ESD/Information Management 
Division, 1777 North Kent Street, RPN, Suite 11000, Arlington, VA 
22209-2133.

    Dated: May 31, 2009.
Patricia L. Toppings,
OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. E9-14427 Filed 6-18-09; 8:45 am]
BILLING CODE 5001-06-P
# Occipital Neuralgia

## What is occipital neuralgia?

Occipital neuralgia is a rare neurological condition that involves shooting, shocking, throbbing, burning, or aching pain and headache that generally starts at the base of the head and spreads along the scalp on one or both sides of the head. It involves the occipital nerves, which run from the area where the spinal column meets the neck, up to the scalp at the back of the head.  

Pain is typically felt in the:
              - Upper neck
              - Back of the head
              - Behind the eyes and ears (usually on one side of the head)
              - Scalp
              - Forehead

The pain usually begins in the neck and then spreads upward. Some people describe the pain as migraine-like. The scalp may become tender and extremely sensitive to the point where a light touch can cause severe pain (allodynia). Causes of occipital neuralgia include injury, pinched nerve, overly tight neck muscles, nerve compression, disc disease, or infection and inflammation.

Diagnosis of occipital neuralgia is usually done through a physical and neurological exam, along with diagnostic imaging. A nerve block (in which a local anesthetic and steroid drug are injected into the area around the nerve) may help with diagnosis. Treatment options include medications, steroid injections, heat, and surgery.  

file-medical

## How can I or a loved one help improve care for people with occipital neuralgia?

Consider participating in a clinical trial so clinicians and scientists can learn more about occipital neuralgia and head and neck pain. Clinical research uses human volunteers to help researchers learn more about a disorder and perhaps find better ways to safely detect, treat, or prevent disease. 

All types of volunteers are needed—those who are healthy or may have an illness or disease—of all different ages, sexes, races, and ethnicities to ensure that study results apply to as many people as possible, and that treatments will be safe and effective for everyone who will use them. 

For information about participating in clinical research visit NIH Clinical Research Trials and You. Learn about clinical trials currently looking for people with occipital neuralgia at Clinicaltrials.gov. 
> Where can I find more information about occipital neuralgia?
Information may be available through the following resource:

American Association of Neurological Surgeons (AANS)Phone: 847-378-0500 or 888-566-2267

book-open
#### In the Matter of Luis Perez, Appellant, v Rochelle Hughes, Respondent.

[822 NYS2d 713]

In a proceeding pursuant to Family Court Act article 6, the father appeals, as limited by his brief, from stated portions of an order of the Family Court, Kings County (Pearl, J.), dated June 2, 2005, which, after a hearing, inter alia, reduced his visitation schedule to each Sunday from 11:30 a.m. until 7:30 p.m.

Ordered that the order is affirmed insofar as appealed from, without costs or disbursements.

“The determination of the Family Court, which saw and heard the witnesses, is entitled to great deference and will not be disturbed unless it lacks a sound and substantial basis in the record” *(Matter of Akyuz v Akyuz,*30 AD3d 511 [2006]; *see Matter of Rho v Rho,*19 AD3d 605, 606 [2005]). Contrary to the father’s contentions, the Family Court’s findings, coupled with the record before us, are sufficient to permit meaningful appellate review *(see*CPLR 4213 [b]), and amply support the court’s determination to modify the father’s visitation schedule *(see Matter of Thaxton v Morro,*222 AD2d 955, 956 [1995]; *see also Matter ofAkyuz v Akyuz, supra).*Adams, J.E, Skelos, Fisher and Covello, JJ., concur.
##### 



Exhibit 99.1

CHIEF EXECUTIVE OFFICER CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Bank of Granite Corporation (the
Company) on Form 10-K for the periods ended December 31, 2002 as filed with
the Securities and Exchange Commission on the date hereof (the Report), I,
John A. Forlines, Jr., Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 that, to the best of my knowledge:

1.     The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

2.     The information contained in the Report fairly presents, in all
material respects, the financial condition and the results of operations of the
Company.

|                     |  |                                                           
|-------------------- |  | ----------------------------------------------------------
|Date: March 10, 2003 |  | /s/ John A. Forlines, Jr.                                 
|                     |  |                                                           
|                     |  | John A. Forlines, Jr.
Chairman and
Chief Executive Officer
NUVA-EX10.1-6-30-2013-10Q




Amendment # 1
To the
Amended and Restated
 2004 Equity Incentive Plan 
of 
NuVasive, Inc. 


WHEREAS, effective as of May 23, 2013 (the “Effective Date”) the Board of Directors of NuVasive, Inc. (the “Company”) agreed to amend the 2004 Amended and Restated Equity Incentive Plan (the “2004 Plan”) pursuant to Section 14.1 of the 2004 Plan with respect to the 2004 Plan’s provisions relating to Awards granted to Non-Employee Directors. 
NOWTHEREFORE, the 2004 Plan shall be amended as of the Effective Date as follows:
1.Section 11.1(a) is amended in its entirety to read as follows:
11.1 Automatic Restricted Stock Unit Grants 
(a) Grant Dates. Stock Awards in the form of restricted stock units (“RSUs”) shall be granted to Non-Employee Directors on the dates specified below: 
(i) Initial Grants. Each Non-Employee Director who is first elected or appointed to the Board at any time on or after the Effective Date shall automatically be granted a RSU Award for the number of shares equal to the quotient of $100,000 divided by the Fair Market Value on the date of such individual’s appointment as Non-Employee Director (the “Initial RSU Grant”), rounded down to the nearest whole share. 
(ii) Annual Grants. As of the Effective Date, on the date of each annual stockholders meeting each individual who is to continue to serve as a Non-Employee Director shall automatically be granted on the date of such meeting a RSU Award for the number of shares equal to the quotient of $120,000 divided by the Fair Market Value on the date of such annual stockholders meeting (the “Annual RSU Grant”), rounded down to the nearest whole share. 
(iii) Annual Grant Proration for New Non-Employee Directors. As of the Effective Date, with respect to a Non-Employee Director who is first elected or appointed after the commencement of the approximately twelve (12) month period beginning on the date of the annual stockholders meeting, such a Non-Employee Director shall receive a prorated Annual RSU Grant determined by multiplying the most recently granted number of RSUs pursuant to Section 11.1(a)(ii), by a fraction, the numerator of which is the difference obtained by subtracting (A) the number of whole months that have elapsed from the date of the last annual meeting of stockholders from (B) twelve (12), and the denominator of which is twelve (12), with the resulting product rounded down to the nearest whole share. 
2.    Except as amended by this Amendment, the 2004 Plan shall remain in full force and effect.  
		
	3.
	Except as otherwise provided in this Amendment, terms used herein shall have the meanings ascribed to such terms in the 2004 Plan.



WEST\225337230.3    1